Vyndaqel (Tafamidis) – Treatment for Transthyretin Familial Amyloid Polyneuropathy

FAP is a hereditary disease caused by the mutation of a TTR gene, located on human chromosome 18q12.1-11.2. Image courtesy of Pfizer.



  • Vyndaqel
  • Vyndaqel for FAP
  • Pfizer Vyndaqel